Lixte Biotech (LIXT) P/E Ratio
P/E Ratio as of Jul 3, 2025: -1.95
Average-0.8214
Median-0.7900
Minimum-1.95
Maximum-0.4900
-1.95
Past Month-0.98 (101.03%)
The P/E ratio for Lixte Biotech (LIXT) is -1.95 as of Jul 3, 2025. This represents a increase of 89.32% compared to its 12-month average P/E ratio of -1.03. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Lixte Biotech P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Lixte Biotech’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Lixte Biotech to industry peers.
Lixte Biotech P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Lixte Biotech’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Lixte Biotech to industry peers.
Lixte Biotech (LIXT) P/E Ratio Insights
See Lixte Biotech’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Lixte Biotech (LIXT)
Order type
Buy in
Order amount
Est. shares
0 shares
Lixte Biotech (LIXT) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jul 1, 2025 | $1.18 | -0.81 |
| Jun 2, 2025 | $1.41 | -0.97 |
| May 1, 2025 | $1.26 | -0.79 |
| Apr 1, 2025 | $1.195 | -0.75 |
| Mar 3, 2025 | $1.21 | -0.68 |
| Feb 3, 2025 | $2.74 | -1.54 |
| Jan 2, 2025 | $2.22 | -1.25 |
Lixte Biotech (LIXT) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -1.95 | +71.05% |
| 2024 | -1.14 | +60.56% |
| 2023 | -0.71 | -37.17% |
| 2022 | -1.13 | -52.52% |
| 2021 | -2.38 | -78.65% |
| 2020 | -11.15 | — |
FAQs About Lixte Biotech (LIXT) P/E ratio
The latest P/E ratio of Lixte Biotech (LIXT) is -1.95, as of Jul 3, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Lixte Biotech’s last 12-month average P/E ratio is -1.03, compared to its current P/E ratio of -1.95. This reflects a increase of 89.32%.
Lixte Biotech’s current P/E ratio of -1.95 is higher than its last 12-month average P/E of -1.03. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Lixte Biotech’s average P/E ratio over the last 3 years is -1.21. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Lixte Biotech’s average P/E ratio over the last 5 years is -3.22. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.